Hsbc Holdings PLC Glaukos Corp Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Glaukos Corp stock. As of the latest transaction made, Hsbc Holdings PLC holds 7,031 shares of GKOS stock, worth $973,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,031

Previous 6,637 5.94%

Holding current value

$973,371

Previous $785,000 16.56%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$113.62 - $135.39 $44,766 - $53,343	394 Added 5.94%	7,031 $915,000
Q2 2024 Aug 12, 2024	SELL	$89.48 - $118.35 $6,263 - $8,284	-70 Reduced 1.04%	6,637 $785,000
Q1 2024 May 15, 2024	BUY	$76.4 - $96.33 $512,414 - $646,085	6,707 New	6,707 $632,000
Q4 2022 Feb 14, 2023	BUY	$40.82 - $57.75 $89,722 - $126,934	2,198 Added 24.26%	11,257 $491,000
Q3 2022 Nov 14, 2022	SELL	$46.84 - $58.49 $161,925 - $202,199	-3,457 Reduced 27.62%	9,059 $499,000
Q2 2022 Aug 11, 2022	SELL	$34.86 - $63.77 $43,819 - $80,158	-1,257 Reduced 9.13%	12,516 $564,000
Q1 2022 May 16, 2022	BUY	$44.33 - $57.82 $238,628 - $311,245	5,383 Added 64.16%	13,773 $821,000
Q4 2021 Feb 11, 2022	SELL	$40.27 - $56.99 $33,585 - $47,529	-834 Reduced 9.04%	8,390 $372,000
Q3 2021 Nov 12, 2021	BUY	$47.43 - $84.23 $437,494 - $776,937	9,224 New	9,224 $448,000
Q2 2021 Aug 13, 2021	SELL	$73.06 - $97.7 $311,893 - $417,081	-4,269 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$70.43 - $97.42 $164,876 - $228,060	-2,341 Reduced 35.42%	4,269 $358,000
Q4 2020 Feb 25, 2021	BUY	$48.9 - $75.26 $323,229 - $497,468	6,610 New	6,610 $497,000
Q2 2019 Aug 13, 2019	SELL	$63.59 - $78.71 $931,911 - $1.15 Million	-14,655 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$50.75 - $80.54 $743,741 - $1.18 Million	14,655 New	14,655 $1.15 Million

Others Institutions Holding GKOS

# of Institutions

340

Shares Held

47.1M

Call Options Held

132K

Put Options Held

188K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.59B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Glaukos Corp Transaction History